Moleculin Biotech, Inc. Accumulated Other Comprehensive Income
Moleculin Biotech, Inc. (MBRX) had Accumulated Other Comprehensive Income of -$64.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-13
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$64.00K.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$52.00K.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $10.00K.
- 2024-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$41.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2026-06-30 | -$64.00K 10-Q · filed 2026-08-13 |
| 2026-03-31 | -$52.00K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $10.00K 10-Q · filed 2026-08-13 |
| 2024-12-31 | -$41.00K 10-K · filed 2026-03-18 |
| 2018-06-30 | $6.00K 10-Q · filed 2018-08-10 |
| 2017-12-31 | $0.00 10-Q · filed 2018-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |